A detailed history of University Of Texas transactions in Novo Nordisk A S stock. As of the latest transaction made, University Of Texas holds 3,684 shares of NVO stock, worth $378,088. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,684
Previous 5,099 27.75%
Holding current value
$378,088
Previous $727,000 39.75%
% of portfolio
0.07%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $168,484 - $205,769
-1,415 Reduced 27.75%
3,684 $438,000
Q2 2024

Sep 17, 2024

BUY
$122.71 - $146.91 $625,698 - $749,094
5,099 New
5,099 $727,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track University Of Texas Portfolio

Follow University Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on University Of Texas with notifications on news.